Federated Hermes Inc. Has $2.14 Million Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Federated Hermes Inc. lessened its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 28.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 34,954 shares of the company’s stock after selling 14,216 shares during the quarter. Federated Hermes Inc.’s holdings in Prestige Consumer Healthcare were worth $2,140,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of PBH. Louisiana State Employees Retirement System bought a new position in Prestige Consumer Healthcare during the fourth quarter worth about $1,518,000. ORG Partners LLC acquired a new stake in shares of Prestige Consumer Healthcare in the 4th quarter valued at approximately $36,000. GHP Investment Advisors Inc. boosted its stake in shares of Prestige Consumer Healthcare by 2.5% in the 4th quarter. GHP Investment Advisors Inc. now owns 86,281 shares of the company’s stock valued at $5,282,000 after purchasing an additional 2,077 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in Prestige Consumer Healthcare by 4.3% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 25,036 shares of the company’s stock worth $1,533,000 after buying an additional 1,024 shares during the period. Finally, Advisors Preferred LLC acquired a new stake in Prestige Consumer Healthcare during the 4th quarter worth approximately $2,447,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Up 0.5 %

PBH stock opened at $70.47 on Monday. The company has a current ratio of 3.09, a quick ratio of 1.92 and a debt-to-equity ratio of 0.75. The company’s 50 day moving average is $70.93 and its 200 day moving average is $64.27. The stock has a market cap of $3.50 billion, a price-to-earnings ratio of -42.97, a price-to-earnings-growth ratio of 1.91 and a beta of 0.52. Prestige Consumer Healthcare Inc. has a 1-year low of $55.96 and a 1-year high of $75.31.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, February 8th. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.02. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. The business had revenue of $282.74 million for the quarter, compared to analysts’ expectations of $280.25 million. During the same period last year, the business earned $1.04 earnings per share. The business’s quarterly revenue was up 2.6% on a year-over-year basis. Sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.33 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on PBH shares. TheStreet upgraded shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, February 12th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, February 10th. One analyst has rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $110.00.

Insider Activity

In other news, SVP Mary Beth Fritz sold 5,336 shares of the stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $69.00, for a total transaction of $368,184.00. Following the completion of the sale, the senior vice president now owns 15,934 shares of the company’s stock, valued at $1,099,446. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.